| Primary |
|
| Visual Disturbance |
100.0% |
|
| Secondary |
| Herpes Zoster |
29.1% |
| Osteoporosis |
10.9% |
| Gastritis |
9.1% |
| Cord Blood Transplant Therapy |
7.3% |
| Hypoparathyroidism |
7.3% |
| Immunosuppression |
7.3% |
| Fungaemia |
5.5% |
| Meningitis Bacterial |
5.5% |
| Constipation |
3.6% |
| Drug Use For Unknown Indication |
3.6% |
| Meningitis |
3.6% |
| Encephalitis Herpes |
1.8% |
| Insomnia |
1.8% |
| Stem Cell Transplant |
1.8% |
| Ventricular Extrasystoles |
1.8% |
|
| Renal Disorder |
28.6% |
| Liver Disorder |
14.3% |
| Toxic Encephalopathy |
14.3% |
| Drug Eruption |
7.1% |
| Hepatic Steatosis |
7.1% |
| Renal Failure |
7.1% |
| Renal Failure Acute |
7.1% |
| Toxic Induced Encephalopathy |
7.1% |
| Vomiting |
7.1% |
|
| Concomitant |
| Infection Prophylaxis |
14.8% |
| Prophylaxis |
14.4% |
| Immunosuppression |
10.2% |
| Allogenic Bone Marrow Transplantation Therapy |
8.6% |
| Stem Cell Transplant |
7.7% |
| Cord Blood Transplant Therapy |
5.4% |
| Multiple Myeloma |
5.3% |
| Prophylaxis Against Graft Versus Host Disease |
5.2% |
| Product Used For Unknown Indication |
4.9% |
| Hiv Infection |
4.5% |
| Asthma |
3.7% |
| Neoplasm Malignant |
3.0% |
| Pneumonia |
1.9% |
| Bone Marrow Conditioning Regimen |
1.8% |
| Platelet Transfusion |
1.6% |
| Antiviral Prophylaxis |
1.4% |
| Bronchitis |
1.4% |
| Otitis Media |
1.4% |
| Packed Red Blood Cell Transfusion |
1.4% |
| Febrile Neutropenia |
1.2% |
|
| Sepsis |
14.9% |
| Renal Impairment |
9.9% |
| Febrile Neutropenia |
8.9% |
| Neutropenia |
7.9% |
| Pyrexia |
5.9% |
| Stomatitis |
5.9% |
| Pneumonia |
5.0% |
| Thrombotic Microangiopathy |
5.0% |
| Venoocclusive Liver Disease |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Renal Disorder |
4.0% |
| Hepatic Function Abnormal |
3.0% |
| Personality Change |
3.0% |
| Pseudomembranous Colitis |
3.0% |
| Respiratory Failure |
3.0% |
| Urine Output Decreased |
3.0% |
| Aspartate Aminotransferase Increased |
2.0% |
| Bladder Perforation |
2.0% |
| C-reactive Protein Increased |
2.0% |
| Cardiac Failure |
2.0% |
|
